🇺🇸 FDA
Patent

US 11298530

Synergistic therapies for intervertebral disc degeneration

granted A61KA61K35/12A61K35/28

Quick answer

US patent 11298530 (Synergistic therapies for intervertebral disc degeneration) held by Discure Technologies Ltd expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Discure Technologies Ltd
Grant date
Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K35/12, A61K35/28, A61K35/30, A61K47/02